Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

Upadacitinib may effectively treat resistant lichen planopilaris.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Hair loss in this case was caused by a tumor, not typical baldness.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.